Please join us for a Symposium on Genomics based biomarker discovery in cancer
At Foundry and Lux, 151 Oyster Point Blvd, South San Francisco, CA on November 19, 2018, 6:00 pm to 9:00 pm PST
|Dr. David Christiani Elkan Blout Professor of Environmental Genetics, Harvard T.H. Chan School of Public Health
Topic: A Multi-Omics Approach for the study of Lung Adenocarcinoma Dr. David’s major research interests are occupational, environmental and molecular epidemiology. He has been interested in studying the impact of exposures to various pollutants on health and the interactions between host factors (genetic and acquired susceptibility), and environmental exposures in producing acute and chronic diseases.
|Dr. Prithwish Pal Sr. Market Development Manager, Oncology, Illumina, Inc.
Topic: Genomic Biomarkers for Immuno-therapy: Tumor Mutational Burden (TMB), and beyond Dr. Prithwish Pal has an unique blend of scientific acumen, business insights and commercial experience to drive development, and global marketing of innovative products and services. His technical and domain knowledge covers a range of fields within the life sciences and clinical spaces, including genomics, bioinformatics and molecular diagnostics.
|Dr. Papia Chakraborty Sr. Scientist and Head of Immuno-oncology, MedGenome Inc.
Topic: TCR-based immunogenicity prediction and screening solutions for immunotherapy research Experienced biomedical researcher with 13 years of wet lab expertise in designing, execution and managing various studies in the areas of immuno-oncology, cell-therapy and cancer-biology.